Wiechen K - Search Results

1

Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer.

Dahl E, Sadr-Nabavi A, Klopocki E, Betz B, Grube S, Kreutzfeld R, Himmelfarb M, An HX, Gelling S, Klaman I, Hinzmann B, Kristiansen G, Grützmann R, Kuner R, Petschke B, Rhiem K, Wiechen K, Sers C, Wiestler O, Schneider A, Höfler H, Nährig J, Dietel M, Schäfer R, Rosenthal A, Schmutzler R, Dürst M, Meindl A, Niederacher D. Dahl E, et al. Among authors: wiechen k. J Pathol. 2005 Jan;205(1):21-8. doi: 10.1002/path.1687. J Pathol. 2005. PMID: 15586368

2

Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene.

Wiechen K, Diatchenko L, Agoulnik A, Scharff KM, Schober H, Arlt K, Zhumabayeva B, Siebert PD, Dietel M, Schäfer R, Sers C. Wiechen K, et al. Am J Pathol. 2001 Nov;159(5):1635-43. doi: 10.1016/S0002-9440(10)63010-6. Am J Pathol. 2001. PMID: 11696424 Free PMC article.

3

Loss of Gelsolin expression in human ovarian carcinomas.

Noske A, Denkert C, Schober H, Sers C, Zhumabayeva B, Weichert W, Dietel M, Wiechen K. Noske A, et al. Among authors: wiechen k. Eur J Cancer. 2005 Feb;41(3):461-9. doi: 10.1016/j.ejca.2004.10.025. Eur J Cancer. 2005. PMID: 15691647

4

c-erbB-2 anti-sense phosphorothioate oligodeoxynucleotides inhibit growth and serum-induced cell spreading of P185c-erbB-2-overexpressing ovarian carcinoma cells.

Wiechen K, Dietel M. Wiechen K, et al. Int J Cancer. 1995 Nov 15;63(4):604-8. doi: 10.1002/ijc.2910630423. Int J Cancer. 1995. PMID: 7591273

5

Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas.

Wiechen K, Sers C, Agoulnik A, Arlt K, Dietel M, Schlag PM, Schneider U. Wiechen K, et al. Am J Pathol. 2001 Mar;158(3):833-9. doi: 10.1016/S0002-9440(10)64031-X. Am J Pathol. 2001. PMID: 11238032 Free PMC article.

6

The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells.

Sers C, Husmann K, Nazarenko I, Reich S, Wiechen K, Zhumabayeva B, Adhikari P, Schröder K, Gontarewicz A, Schäfer R. Sers C, et al. Among authors: wiechen k. Oncogene. 2002 Apr 25;21(18):2829-39. doi: 10.1038/sj.onc.1205377. Oncogene. 2002. PMID: 11973642

7

Selection of a high activity c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent protein.

Wiechen K, Zimmer C, Dietel M. Wiechen K, et al. Cancer Gene Ther. 1998 Jan-Feb;5(1):45-51. Cancer Gene Ther. 1998. PMID: 9476966

8

Involvement of the c-erbB-2 oncogene product in the EGF-induced cell motility of SK-OV-3 ovarian cancer cells.

Wiechen K, Karaaslan S, Dietel M. Wiechen K, et al. Int J Cancer. 1999 Oct 29;83(3):409-14. doi: 10.1002/(sici)1097-0215(19991029)83:3<409::aid-ijc18>3.0.co;2-#. Int J Cancer. 1999. PMID: 10495435

9

Gene expression profiling in RAS oncogene-transformed cell lines and in solid tumors using subtractive suppression hybridization and cDNA arrays.

Sers C, Tchernitsa OI, Zuber J, Diatchenko L, Zhumabayeva B, Desai S, Htun S, Hyder K, Wiechen K, Agoulnik A, Scharff KM, Siebert PD, Schäfer R. Sers C, et al. Among authors: wiechen k. Adv Enzyme Regul. 2002;42:63-82. doi: 10.1016/s0065-2571(01)00024-3. Adv Enzyme Regul. 2002. PMID: 12123707 No abstract available.

10

Antisense phosphorothioate oligodeoxynucleotide down-regulation of the insulin-like growth factor I receptor in ovarian cancer cells.

Müller M, Dietel M, Turzynski A, Wiechen K. Müller M, et al. Among authors: wiechen k. Int J Cancer. 1998 Aug 12;77(4):567-71. doi: 10.1002/(sici)1097-0215(19980812)77:4<567::aid-ijc16>3.0.co;2-3. Int J Cancer. 1998. PMID: 9679760

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters